Friday, July 10, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,798
Companies 1,771
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,798 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 9 of 200 · By data quality, then INN

  1. clemastine fumarate

    TAVIST Teva Pharma GmbH

    ORAL FDA: approved

  2. clindamycin hydrochloride

    CLINDAMYCIN HYDROCHLORIDE Teva Pharma GmbH

    ORAL FDA: approved

  3. clindamycin palmitate hydrochloride

    CLINDAMYCIN PALMITATE HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  4. clindamycin phosphate

    CLINDAMYCIN PHOSPHATE Amneal Pharma Europe Ltd

    TOPICAL FDA: approved

  5. clobazam

    CLOBAZAM Amneal Pharma Europe Ltd

    ORAL FDA: approved

  6. clobetasol propionate

    CLOBETASOL PROPIONATE Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  7. clofarabine

    EVOLTRA Amneal Pharma Europe Ltd

    INJECTION FDA: approved · EMA: approved

    L01BB06

  8. clofibrate

    CLOFIBRATE Teva Pharma GmbH

    ORAL FDA: approved

  9. clomipramine hydrochloride

    CLOMIPRAMINE HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  10. clonazepam

    PAXAM 0.5 Alphapharm Pty Ltd

    ORAL FDA: approved · TGA: approved

  11. clonidine hydrochloride

    CLONIDINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  12. clopidogrel

    BLOOMS CLOPIDOGREL Alphapharm Pty Ltd

    EMA: approved · TGA: approved · NMPA: clinical trials

    B01AC04

  13. clopidogrel bisulfate

    CLOPIDOGREL BISULFATE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  14. clorazepate dipotassium

    CLORAZEPATE DIPOTASSIUM Quantum Biopharma

    ORAL FDA: approved

  15. clotrimazole

    APO-CLOTRIMAZOLE 3 DAY CREAM Alphapharm Pty Ltd

    TOPICAL FDA: approved · TGA: approved

  16. cloxacillin sodium

    CLOXACILLIN SODIUM Teva Pharma GmbH

    ORAL FDA: approved

  17. clozapine

    CLOPINE 100 Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

  18. codeine phosphate

    PHERAZINE VC W/ CODEINE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  19. colchicine

    ARX-COLCHICINE Lacuna Pharma Pty Ltd

    ORAL FDA: approved · EMA: unknown · TGA: approved · NMPA: clinical trials

    M04AC01

  20. colesevelam hydrochloride

    COLESEVELAM HYDROCHLORIDE United Therapeutics Europe Ltd

    ORAL FDA: approved

  21. colistimethate sodium

    COLOBREATHE Essential Pharma Limited

    INJECTION FDA: approved · EMA: approved

    J01XB01

  22. conivaptan hydrochloride

    VAPRISOL CUMBERLAND PHARMACEUTICALS INC

    INJECTION FDA: approved

  23. cortisone acetate

    CORTONE Teva Pharma GmbH

    INJECTION FDA: approved

  24. cosyntropin

    COSYNTROPIN Amphastar France Pharmaceuticals

    INJECTION FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,798 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.